Understanding GeoVax Labs’ Groundbreaking COVID-19 Vaccine Candidate
Introduction to GeoVax Labs GeoVax Labs is making headlines with its next-generation COVID-19 vaccine candidate, geo-cm04s1. This innovative vaccine is currently undergoing three pivotal phase 2 trials, each targeting different patient groups. Understanding the scope and implications of these trials can shed light on the future of COVID-19 vaccinations. Trial Focus Areas The three ongoing … Read more